Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 CAD | +2.35% |
|
-6.44% | +12.96% |
Jun. 26 | Nervgen Pharma Initiated at Market Perform, $3 Price Target at Raymond James | MT |
Jun. 25 | NervGen Pharma to Advance New Drug Candidate into Preclinical Proof-of-Concept Stage | MT |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- Other languages